CYTOCHEMICAL AND IMMUNOCYTOCHEMICAL STUDIES Of THYROID PEROXIDASE’ EXPRESSION IN PREOPERATIVE DIAGNOSIS OF THYROID PAPILLARY CARCINOMA AND ITS RADIOIODINE RESISTANT METASTASES
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-21-3-2019-g.7925Keywords:
fine-needle-aspiration puncture biopsy, metastases, papillary carcinoma, radioiodine resistance, thyroid gland, thyroid peroxidaseAbstract
Objective: determination of thyroid peroxidase’ (TPO) expression in punctates of thyroid gland tumors (TG) and postoperative metastases of papillary thyroid cancer; comparison of the effectiveness of cytochemical and immunocytochemical methods for determining the expression of enzyme to surgical intervention for prediction of radioiodine resistance of the mentioned type of carcinoma. Object and methods: immunocytochemical and cytochemical investigations were performed on the material of aspiration puncture biopsies in 30 patients with malignant and 33 with benign thyroid tumors, as well as in the study of 20 metastases detected after thyroidectomy and radioiodine therapy (10 — radioiodine susceptible, 10 — radioiodine resistant metastases). An indirect immunoperoxidase method was used using McAB to TPO. The benzidine method modified by the authors was used for cytochemical detection of TPO activity. Results: with our adapted cytochemical method of detection of TPO activity in punctates, it has been proved that in most benign tumors all epithelial cells exhibited this activity. On the contrary, none of the carcinomas studied did not meet, at which point this activity would have all epithelial cells. This suggests that the method of cytochemical detection of TPO activity in FNA smears is useful in preoperative cytological differential diagnosis of thyroid tumors. Pretty high indicators of accuracy of positive prediction (100%), specificity (88%) and sensitivity (70%) of the method indicate its usefulness. The results of TPO expression in papillary thyroid carcinoma metastases detected in the postoperative period, obtained using cytochemical and immunocytochemical methods, coincide and demonstrate that both methods may be suitable for preoperative prediction of radioiodine resistance of papillary thyroid carcinoma. Conclusions: modification of the cytochemical determination of TPO activity in the epithelium of punctates is effective in the differential cytological diagnosis of malignant and benign thyroid tumors. The coincidence of the results of cytochemical and immunocytochemical methods for the investigation of TPO expression in epithelium of punctates of postoperative radioiodine resistance and radioiodine-sensitive metastases substantiates the possibility of using both methods in preoperative prediction of radioiodine resistance of papillary thyroid carcinoma.
References
Dunn JT, Dunn AD. Update on intrathyroidal iodine metabolism. Thyroid 2001; 11 (5): 407–17.
De la Vieja A, Santisteban P. Role of iodide metabolism in physiology and cancer. Endocrine-related cancer 2018; 25 (4): 225–45.
Mansourian AR. Metabolic pathways of tetraidothyronine and triidothyronine production by thyroid gland: a review of articles. Pak J Biol Sci 2011; 14 (1): 1–12.
Godlewska M, Arczewska KD. Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties. PLoS One 2017; 12 (6): e0179066.
Furuya F, Shimura H, Hideyo S, et al. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin. Cancer 2004; 145 (6): 2865.
Liu Ying, Marcel P, Stokkel L, et al. Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma. European J Endocrinology 2006; 154 (4): 525–31.
Markovina S, Grigsby P, Schwarz J, et al. Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. Thyroid 2014; 24 (7): 1121–26.
Haugen B, Alexander E, Bible K, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodule sand differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26 (1): 1–133.
Pulcrano M, Boukheris H, Talbot M, et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of the histological classification. Thyroid 2007; 17: 639–46.
Caballero Y, López-Tomassetti EM, Favre J, et al. The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer — a long-term follow-up study. Thyroid Res 2015; 8: 12.
Czarnocka B, Pastuszko D, Janota-Bzowski M, et al. Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer? British Journal of Cancer, 2001; 85 (6): 875–80.
Mizukami Y, Matsubara F. Correlation between thyroid peroxidase activity and histopathological and ultrastructural changes in various thyroid diseases. Endocrinol Jpn 1981; 28 (4): 381–9.
De Micco C, Savchenko V, Giorgi R, et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: Comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. Br J Cancer 2008; 98 (4): 818–23.
Paunovic I, Isic T, Havelka M, et al. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors. APMIS 2012; 120: 368–79.
Savin S, Cvejic D, Isic T, et al. Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors. Endocr Pathol 2006; 17: 53–60.
Hoperia V. Immunocytochemical (HBME-1, TPO) and cytochemical (DAP 4) study after TAPB nodes of the thyroid gland. Clinical endocrinology and endocrine surgery 2010; 3 (32): 9–14. (in Ukrainian).
Smejkal V. A new method for the cytochemical demonstration of peroxidase activity for light, fluorescence, electron microscopy. J histoch cytochemistry 1976; 24: 82–90.
Shtange MB. Detection of iodine peroxidase activity in the thyroid gland of human fetuses. Probl endocrinology 1968; 2: 88–94.
Ofverholm T, Ericson LE. Diffusion artefacts and tissue fixation in thyroperoxidase cytochemistry. Histochemistry 1984; 81 (1): 1–8.
Zelinskaya HV. Cytokeratin 17 and thyroid peroxidase as immunocytochemical markers for preoperative prediction of radioiodine resistance and the effectiveness of radioiodine therapy of papillary thyroid carcinoma. Oncology 2019; 21 (1): 31–5. (in Ukrainian)
